UA23882A - METHOD OF TREATMENT OF DUODENAL DISEASE - Google Patents

METHOD OF TREATMENT OF DUODENAL DISEASE

Info

Publication number
UA23882A
UA23882A UA96020653A UA96020653A UA23882A UA 23882 A UA23882 A UA 23882A UA 96020653 A UA96020653 A UA 96020653A UA 96020653 A UA96020653 A UA 96020653A UA 23882 A UA23882 A UA 23882A
Authority
UA
Ukraine
Prior art keywords
treatment
dalargin
intense pain
duodenal ulcer
disease
Prior art date
Application number
UA96020653A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Микола Полікарпович Буглак
Алєксандр Hіколаєвіч Богданов
Микола Миколайович Богданов
Віктор Андрійович Гончаренко
Виктор Андреевич Гончаренко
Original Assignee
Кримський Медичний Інститут
Крымский Медицинский Институт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кримський Медичний Інститут, Крымский Медицинский Институт filed Critical Кримський Медичний Інститут
Priority to UA96020653A priority Critical patent/UA23882A/en
Publication of UA23882A publication Critical patent/UA23882A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Предметом изобретения является способ лечения язвенной болезни двенадцатиперстной кишки даларгином и спазмолитиками. При язвенной болезни, сопровождающейся спастическими явлениями в гастродуоденальной зоне и интенсивным болевым синдромом, дополнительно к введению даларгина по стандартной методике применяется миотропный спазмолитик папаверина гидрохлорид в качестве противоязвенного (антиульцерогенного) средства в терапевтических дозах. Изобретение относится к медицине, в частности, к гастроэнтерологии и может быть использованным для лечения язвенной болезни двенадцатиперстной кишки с интенсивным болевым синдромом и выраженными спастическими явлениями в гастродуоденальной зоне.The subject of the invention is a method for the treatment of duodenal ulcer with dalargin and antispasmodics. In case of peptic ulcer disease, accompanied by spastic phenomena in the gastroduodenal zone and intense pain syndrome, in addition to the administration of dalargin, the myotropic antispasmodic papaverine hydrochloride is used as an antiulcer (antiulcerogenic) agent in therapeutic doses according to the standard technique. The invention relates to medicine, in particular to gastroenterology and can be used to treat duodenal ulcer with intense pain and severe spastic phenomena in the gastroduodenal zone.

UA96020653A 1996-02-21 1996-02-21 METHOD OF TREATMENT OF DUODENAL DISEASE UA23882A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA96020653A UA23882A (en) 1996-02-21 1996-02-21 METHOD OF TREATMENT OF DUODENAL DISEASE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA96020653A UA23882A (en) 1996-02-21 1996-02-21 METHOD OF TREATMENT OF DUODENAL DISEASE

Publications (1)

Publication Number Publication Date
UA23882A true UA23882A (en) 1998-08-31

Family

ID=74315175

Family Applications (1)

Application Number Title Priority Date Filing Date
UA96020653A UA23882A (en) 1996-02-21 1996-02-21 METHOD OF TREATMENT OF DUODENAL DISEASE

Country Status (1)

Country Link
UA (1) UA23882A (en)

Similar Documents

Publication Publication Date Title
LU92098I2 (en) Adalimumab and its pharmaceutically acceptable derivatives (HUMIRA®)
DE69532961D1 (en) USE OF PORPHYRINE IN THE TREATMENT OF MULTIPLE Sclerosis
ATE155043T1 (en) TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES
RU94028105A (en) NEW HETEROARYL DERIVATIVES, INTERMEDIATE CONNECTIONS FOR THEIR RECEPTION, PHARMACEUTICAL ON THEIR BASIS, METHOD OF TREATING PSYCHOSES AND METHOD OF LIGHTENING PAIN
PT646012E (en) CURE OF WOUNDS AND TREATMENT OF FIBROTIC PERTURBACTIONS BY TGFBETA-3
AU2005202257C1 (en) Azacyclic compounds for use in the treatment of serotonin related diseases
PT880350E (en) MULTIPLE SCLEROSIS TREATMENT
ATE293451T1 (en) TREATMENT OF OSTEOARTHRITIS BY ADMINISTRATION OF POLY-N-ACETYL-D-GLUCOSAMINE
DE69424777D1 (en) 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS
FI885166A0 (en) FOERFARANDE FOER SAENKNING AV MAENGDEN KVAEVEOXIDER I AVGASER MED ANVAENDNING AV SOCKER.
DE69328838D1 (en) ANTIPYRETIC AND ANALGETIC METHODS AND COMPOSITIONS CONTAINING OPTICALLY PURE R-ETODOLAC
NO20083276L (en) Treatment of diabetes with thiazolidinedione and sulfonylurea
FR2533563B1 (en)
UA23882A (en) METHOD OF TREATMENT OF DUODENAL DISEASE
TW259710B (en)
HK1015692A1 (en) Ctla-8 in combination with g-csf or with g-csf and il-6, and use of ctla-8, for treating infections
MX9302985A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PROPHYLAXIS OF ANXIETY.
SE8804640D0 (en) MEDICAMENT COMPRISING CYCLOLINOPEPTIDE A
ATE271867T1 (en) TREATMENT OF URINARY INCONTINENCE AND COMPOSITION THEREOF
RU94007838A (en) METHOD OF TREATING HEMORRHAGIC FEVER WITH RENEWAL SYNDROME
RU1836951C (en) Antiulcerous agent
NO964291L (en) Procedure for the treatment of allergic rhinitis
SU1187821A1 (en) Method of treatment of secondury recurrent syphilis
SE9000658D0 (en) METHOD FOR TREATMENT OF SLEEP APNOE
UA12417A (en) Method for treatment of the duodenal ulcer